Bacterial Sphingolipids Exacerbate Colitis by Inhibiting ILC3-derived IL-22 Production
暂无分享,去创建一个
S. Snapper | Dennis L. Kasper | Dingding An | Meng Wu | Izabel Patik | Jared Barends | Bin Bao | Jodie Ouahed | Youyuan Wang | Pavl Boudreau | Xinyang Song | Xi Chen | Ying Tang | Amit Ringel | Chuan Wu | Emily Balskus | Jay Thiagarajah | Jian Liu | Michael R. Wessels | Wayne Lencer | Bruce Horwitz | M. R. Wessels
[1] Jialie Luo,et al. Lipids regulate peripheral serotonin release via gut CD1d. , 2023, Immunity.
[2] P. Bousso,et al. Inflammation triggers ILC3 patrolling of the intestinal barrier , 2022, Nature Immunology.
[3] E. Mekada,et al. Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation , 2022, Nature Immunology.
[4] S. Signoretti,et al. From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit. , 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] J. Rossjohn,et al. Host immunomodulatory lipids created by symbionts from dietary amino acids , 2021, Nature.
[6] Xia Luo,et al. Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s , 2021, Acta Pharmacologica Sinica.
[7] E. Chang,et al. The Gut Microbiome and Inflammatory Bowel Diseases. , 2021, Annual review of medicine.
[8] A. Theiss,et al. NLRP6 in host defense and intestinal inflammation , 2021, Cell reports.
[9] F. Pan,et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity , 2020, Nature Communications.
[10] Gregory F. Sonnenberg,et al. Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut. , 2020, Trends in immunology.
[11] E. Elinav,et al. Interaction between microbiota and immunity in health and disease , 2020, Cell Research.
[12] R. Ley,et al. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels , 2020, Nature Communications.
[13] V. Sexl,et al. Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation , 2020, Nature Communications.
[14] T. Yi,et al. The role of IL-22 in intestinal health and disease , 2020, The Journal of experimental medicine.
[15] Mitchell Kronenberg,et al. The role of innate lymphoid cells in response to microbes at mucosal surfaces , 2020, Mucosal Immunology.
[16] W. Garrett,et al. Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity. , 2019, Immunity.
[17] S. Summers,et al. Metabolic Messengers: ceramides , 2019, Nature Metabolism.
[18] H. Vlamakis,et al. Microbial genes and pathways in inflammatory bowel disease , 2019, Nature Reviews Microbiology.
[19] M. Colonna,et al. Innate Lymphoid Cells in Mucosal Immunity , 2019, Front. Immunol..
[20] Cheng Huang,et al. Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects , 2019, Cellular & Molecular Immunology.
[21] W. Ouyang,et al. IL‐10 Family Cytokines IL‐10 and IL‐22: from Basic Science to Clinical Translation , 2019, Immunity.
[22] H. Glatt,et al. Interleukin-22 protects intestinal stem cells against genotoxic stress , 2019, Nature.
[23] W. Mohn,et al. IL-22 Preserves Gut Epithelial Integrity and Promotes Disease Remission during Chronic Salmonella Infection , 2019, The Journal of Immunology.
[24] S. Targan,et al. Microbiota‐Induced TNF‐like Ligand 1A Drives Group 3 Innate Lymphoid Cell‐Mediated Barrier Protection and Intestinal T Cell Activation during Colitis , 2018, Immunity.
[25] C. Huttenhower,et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease , 2018, Nature Microbiology.
[26] R. Locksley,et al. Innate Lymphoid Cells: 10 Years On , 2018, Cell.
[27] R. Ley,et al. Sphingolipids in host-microbial interactions. , 2018, Current opinion in microbiology.
[28] D. Danilenko,et al. Pre‐clinical and translational pharmacology of a human interleukin‐22 IgG fusion protein for potential treatment of infectious or inflammatory diseases , 2018, Biochemical pharmacology.
[29] M. Hepworth,et al. Group 3 Innate Lymphoid Cells: Communications Hubs of the Intestinal Immune System , 2017, Front. Immunol..
[30] Michael C. Ostrowski,et al. IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB , 2017, The Journal of Immunology.
[31] L. Albenberg,et al. Gut microbiota and IBD: causation or correlation? , 2017, Nature Reviews Gastroenterology &Hepatology.
[32] G. Besra,et al. CD1d‐mediated activation of group 3 innate lymphoid cells drives IL‐22 production , 2016, EMBO reports.
[33] J. Mjösberg,et al. Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease , 2016, Current Allergy and Asthma Reports.
[34] W. Garrett,et al. Gut microbiota, metabolites and host immunity , 2016, Nature Reviews Immunology.
[35] I. Amit,et al. Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling , 2015, Cell.
[36] M. Farrar,et al. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria–specific CD4+ T cells , 2015, Science.
[37] E. O’Toole,et al. Metalloproteinases and Wound Healing. , 2015, Advances in wound care.
[38] H. Spits,et al. The biology of innate lymphoid cells , 2015, Nature.
[39] D. Kasper,et al. Deciphering the tête-à-tête between the microbiota and the immune system. , 2014, The Journal of clinical investigation.
[40] Emily R. Miraldi,et al. CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22 , 2014, The Journal of experimental medicine.
[41] Sarah Spiegel,et al. Sphingolipid metabolites in inflammatory disease , 2014, Nature.
[42] Y. Belkaid,et al. Microbiota-Dependent Crosstalk Between Macrophages and ILC3 Promotes Intestinal Homeostasis , 2014, Science.
[43] Y. Cong,et al. Microbiota regulation of inflammatory bowel disease. , 2014, Inflammation & allergy drug targets.
[44] S. Zeissig,et al. Sphingolipids from a Symbiotic Microbe Regulate Homeostasis of Host Intestinal Natural Killer T Cells , 2014, Cell.
[45] C. Rock,et al. Bacterial lipids: metabolism and membrane homeostasis. , 2013, Progress in lipid research.
[46] M. Fischbach,et al. Production of α-Galactosylceramide by a Prominent Member of the Human Gut Microbiota , 2013, PLoS biology.
[47] R. Siebert,et al. Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function , 2012, Science.
[48] D. Kasper,et al. The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA , 2012, Immunological reviews.
[49] V. Tremaroli,et al. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88 , 2011, Gut.
[50] Hans Clevers,et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.
[51] Richard A. Flavell,et al. NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.
[52] M. Lamkanfi,et al. IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation , 2010, The Journal of Immunology.
[53] S. Mazmanian,et al. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.
[54] J. Tschopp,et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome , 2010, Gut.
[55] N. Beauchemin,et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. , 2010, Immunity.
[56] M. Neurath,et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing , 2009, The Journal of experimental medicine.
[57] S. Sa,et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens , 2008, Nature Medicine.
[58] C. Raetz,et al. Lipid A modification systems in gram-negative bacteria. , 2007, Annual review of biochemistry.
[59] L. Hooper,et al. Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin , 2006, Science.
[60] D. Ho,et al. Recognition of bacterial glycosphingolipids by natural killer T cells , 2005, Nature.
[61] I. Olsen,et al. Sphingolipids in Bacteria and Fungi , 2001 .
[62] Judy H. Cho. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2016 .
[63] 高山 哲朗. Imbalance of NKp44[+]NKp46[-] and NKp44[-]NKp46[+] natural killer cells in the intestinal mucosa of patients with Crohn's disease , 2011 .
[64] Margaret Comerford Freda,et al. 10 Years. , 2008, MCN. The American journal of maternal child nursing.